Listed by the USPTO as CHESTNUT, BARRY A
Tech Center 1600 • Art Units: 1646 1648 1671 1672
This examiner grants 74% of resolved cases
CHESTNUT, BARRY A is assigned to tech center 1600 and art unit 1646. The profile records 766 resolved cases, with an allowance rate of 74.0% and a median of 993 days to allowance. The large docket shows allowance in most recorded cases, while the median timing indicates that applicants should plan for a substantial prosecution period.
The 6.2% interview lift is limited, placing greater practical weight on the written record and claim strategy. The principal companies are Zoetis LLC, The Board of Trustees of the Leland Stanford Junior University, and Merck Sharp & Dohme LLC. The leading firms are BANNER & WITCOFF, LTD., BOZICEVIC, FIELD & FRANCIS LLP, and Casimir Jones, S.C.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18894405 | OIL-BASED ADJUVANTS | Non-Final OA | Zoetis Services LLC |
| 18721719 | COMPOSITIONS AND METHODS FOR PREVENTION OF PISCINE MYOCARDITIS | Non-Final OA | Zoetis Services LLC |
| 18364753 | GLYCAN MODIFIED NUCLEIC ACIDS, METHODS OF PREPARATION, AND THERAPEUTIC USES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18769900 | SCALABLE CHROMATOGRAPHY PROCESS FOR PURIFICATION OF HUMAN CYTOMEGALOVIRUS | Non-Final OA | Merck Sharp & Dohme LLC |
| 18701156 | MRNA VACCINE DESIGN VIA THE ALTERATION OF CODON USAGE | Non-Final OA | The Cleveland Clinic Foundation |
| 18827183 | SELF-REPLICATING RNA AND USES THEREOF | Non-Final OA | TRUSTEES OF BOSTON UNIVERSITY |
| 18794860 | FELINE LEUKEMIA VIRUS VACCINE | Non-Final OA | INTERVET INC. |
| 18744397 | Method of Generating Phage Clones with Expanded Activity | Non-Final OA | The Government of the United States, as Represented by The Secretary of The Army |
| 18658604 | SELF-AMPLIFYING RNA COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | Gritstone bio, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy74.0% of resolved applications examined by Barry A Chestnut were allowed (766 resolved cases), compared with 41.0% across Art Unit 1646 over the last five years.
This examiner's interview lift is +6.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Barry A Chestnut took 993 days on average from filing to allowance.
Barry A Chestnut examines applications in Art Unit 1646 in Tech Center 1600 (Biotechnology & Pharmaceuticals).